Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1992 Aug;157(2):195–196.

Recombinant erythropoietin therapy in renal and nonrenal anemia.

A J Erslev
PMCID: PMC1011260  PMID: 1441490

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baer A. N., Dessypris E. N., Goldwasser E., Krantz S. B. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol. 1987 Aug;66(4):559–564. doi: 10.1111/j.1365-2141.1987.tb01344.x. [DOI] [PubMed] [Google Scholar]
  2. Bessho M., Jinnai I., Matsuda A., Saito M., Hirashima K. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int J Cell Cloning. 1990 Nov;8(6):445–458. doi: 10.1002/stem.5530080647. [DOI] [PubMed] [Google Scholar]
  3. Bondurant M. C., Koury M. J. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol. 1986 Jul;6(7):2731–2733. doi: 10.1128/mcb.6.7.2731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyd H. K., Lappin T. R. Erythropoietin deficiency in the anaemia of chronic disorders. Eur J Haematol. 1991 Apr;46(4):198–201. doi: 10.1111/j.1600-0609.1991.tb00540.x. [DOI] [PubMed] [Google Scholar]
  5. Bunn H. F. Recombinant erythropoietin therapy in cancer patients. J Clin Oncol. 1990 Jun;8(6):949–951. doi: 10.1200/JCO.1990.8.6.949. [DOI] [PubMed] [Google Scholar]
  6. Caro J., Erslev A. J. Uremic inhibitors of erythropoiesis. Semin Nephrol. 1985 Jun;5(2):128–132. [PubMed] [Google Scholar]
  7. Cazzola M., Ponchio L., Beguin Y., Rosti V., Bergamaschi G., Liberato N. L., Fregoni V., Nalli G., Barosi G., Ascari E. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood. 1992 Jan 1;79(1):29–37. [PubMed] [Google Scholar]
  8. ERSLEV A. Humoral regulation of red cell production. Blood. 1953 Apr;8(4):349–357. [PubMed] [Google Scholar]
  9. Erslev A. J. In vitro production of erythropoietin by kidneys perfused with a serum-free solution. Blood. 1974 Jul;44(1):77–85. [PubMed] [Google Scholar]
  10. Eschbach J. W., Mladenovic J., Garcia J. F., Wahl P. W., Adamson J. W. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo. J Clin Invest. 1984 Aug;74(2):434–441. doi: 10.1172/JCI111439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eschbach J. W. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989 Jan;35(1):134–148. doi: 10.1038/ki.1989.18. [DOI] [PubMed] [Google Scholar]
  12. Fischl M., Galpin J. E., Levine J. D., Groopman J. E., Henry D. H., Kennedy P., Miles S., Robbins W., Starrett B., Zalusky R. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med. 1990 May 24;322(21):1488–1493. doi: 10.1056/NEJM199005243222103. [DOI] [PubMed] [Google Scholar]
  13. Hellström E., Birgegård G., Lockner D., Helmers C., Ost A., Wide L. Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol. 1991 Nov;47(5):355–360. doi: 10.1111/j.1600-0609.1991.tb01860.x. [DOI] [PubMed] [Google Scholar]
  14. JACOBSON L. O., GOLDWASSER E., FRIED W., PLZAK L. Role of the kidney in erythropoiesis. Nature. 1957 Mar 23;179(4560):633–634. doi: 10.1038/179633a0. [DOI] [PubMed] [Google Scholar]
  15. Jelkmann W., Pagel H., Wolff M., Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci. 1992;50(4):301–308. doi: 10.1016/0024-3205(92)90338-p. [DOI] [PubMed] [Google Scholar]
  16. Ludwig H., Fritz E., Kotzmann H., Höcker P., Gisslinger H., Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med. 1990 Jun 14;322(24):1693–1699. doi: 10.1056/NEJM199006143222402. [DOI] [PubMed] [Google Scholar]
  17. Miller C. B., Jones R. J., Piantadosi S., Abeloff M. D., Spivak J. L. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med. 1990 Jun 14;322(24):1689–1692. doi: 10.1056/NEJM199006143222401. [DOI] [PubMed] [Google Scholar]
  18. Pincus T., Olsen N. J., Russell I. J., Wolfe F., Harris E. R., Schnitzer T. J., Boccagno J. A., Krantz S. B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med. 1990 Aug;89(2):161–168. doi: 10.1016/0002-9343(90)90294-n. [DOI] [PubMed] [Google Scholar]
  19. Pinevich A. J., Petersen J. Erythropoietin therapy in patients with chronic renal failure. West J Med. 1992 Aug;157(2):154–157. [PMC free article] [PubMed] [Google Scholar]
  20. Schouten H. C., Vellenga E., van Rhenen D. J., de Wolf J. T., Coppens P. J., Blijham G. H. Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia. 1991 May;5(5):432–436. [PubMed] [Google Scholar]
  21. Sherwood J. B., Goldwasser E., Chilcote R., Carmichael L. D., Nagel R. L. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood. 1986 Jan;67(1):46–49. [PubMed] [Google Scholar]
  22. Spivak J. L., Barnes D. C., Fuchs E., Quinn T. C. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989 Jun 2;261(21):3104–3107. [PubMed] [Google Scholar]
  23. Stebler C., Tichelli A., Dazzi H., Gratwohl A., Nissen C., Speck B. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study. Exp Hematol. 1990 Dec;18(11):1204–1208. [PubMed] [Google Scholar]
  24. Stein R. S., Abels R. I., Krantz S. B. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood. 1991 Oct 1;78(7):1658–1663. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES